4D Molecular Therapeutics GAAP EPS of -$1.08 misses by $0.03, revenue of $4.15M beats by $1.05M
Open the sourceReported by Seeking Alpha, seekingalpha.com, 12 November 2026
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Muhabbit only has the headline for this one. The full report is at seekingalpha.com.